Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew McPartlin

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Oral Oncology|November 22, 2023
Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal cancerJohn Gaffney, Amaila Ramzan, Teresa Dinizulu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2022
Corrigendum to "Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharynx cancer: A multi-centre study" [Radiother. Oncol. 172 (2022) 111-117]James M Price, Catharine M West, Lynne M Dixon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 25, 2020
Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of lifeNoelia Sanmamed, Jenny Lee, Alejandro Berlin, et al.
Oral Oncology|April 20, 2025
Development of a patient reported outcomes based machine learning model to predict recurrences in head and neck cancerChristopher M K L Yao, Katrina Hueniken, Shao Hui Huang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 14, 2018
Use of a novel atlas for muscles of mastication to reduce inter observer variability in head and neck radiotherapy contouringChristina Hague, William Beasley, Lynne Dixon, et al.
Neoplasia (New York, N.Y.)|May 17, 2025
Differential prognostic association of systemic inflammatory biomarkers on survival outcomes in head and neck squamous cell carcinoma patients by human papillomavirus statusPardis Noormohammadpour, Katrina Hueniken, Martha Pienkowski, et al.
Physics and Imaging in Radiation Oncology|January 13, 2025
Translation of dynamic contrast-enhanced imaging onto a magnetic resonance-guided linear accelerator in patients with head and neck cancerMichael J Dubec, Michael Berks, James Price, et al.
Journal of Medical Systems|March 9, 2026
Machine Learning Models for Individualized Osteoradionecrosis Risk Prediction in Head and Neck CancerMohammad Moharrami, Erin Watson, Shao Hui Huang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 22, 2025
Defining the optimal radiation thresholds for Stratifying jaw osteoradionecrosis risk in head and neck cancerMohammad Moharrami, Erin Watson, Shao Hui Huang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2025
The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trialKara M Ruicci, Aisling Barry, Xiang Y Ye, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Oral Oncology|November 22, 2023
Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal cancerJohn Gaffney, Amaila Ramzan, Teresa Dinizulu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2022
Corrigendum to "Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharynx cancer: A multi-centre study" [Radiother. Oncol. 172 (2022) 111-117]James M Price, Catharine M West, Lynne M Dixon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 25, 2020
Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of lifeNoelia Sanmamed, Jenny Lee, Alejandro Berlin, et al.
Oral Oncology|April 20, 2025
Development of a patient reported outcomes based machine learning model to predict recurrences in head and neck cancerChristopher M K L Yao, Katrina Hueniken, Shao Hui Huang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 14, 2018
Use of a novel atlas for muscles of mastication to reduce inter observer variability in head and neck radiotherapy contouringChristina Hague, William Beasley, Lynne Dixon, et al.
Neoplasia (New York, N.Y.)|May 17, 2025
Differential prognostic association of systemic inflammatory biomarkers on survival outcomes in head and neck squamous cell carcinoma patients by human papillomavirus statusPardis Noormohammadpour, Katrina Hueniken, Martha Pienkowski, et al.
Physics and Imaging in Radiation Oncology|January 13, 2025
Translation of dynamic contrast-enhanced imaging onto a magnetic resonance-guided linear accelerator in patients with head and neck cancerMichael J Dubec, Michael Berks, James Price, et al.
Journal of Medical Systems|March 9, 2026
Machine Learning Models for Individualized Osteoradionecrosis Risk Prediction in Head and Neck CancerMohammad Moharrami, Erin Watson, Shao Hui Huang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 22, 2025
Defining the optimal radiation thresholds for Stratifying jaw osteoradionecrosis risk in head and neck cancerMohammad Moharrami, Erin Watson, Shao Hui Huang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2025
The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trialKara M Ruicci, Aisling Barry, Xiang Y Ye, et al.
Pageof 6